ai – Page 3 – Market Industry Forecast News

Patient Engagement Solutions Market Challenges: Addressing User Adoption and Trust Issues

The global patient engagement solutions market was valued at approximately USD 22.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.7% from 2024 to 2030. Key drivers for this growth include ongoing technological advancements, the increasing adoption of Electronic Health Records (EHR) and mobile health (mHealth) solutions, the rising prevalence of chronic diseases, supportive initiatives from major stakeholders, and a growing consumer focus on healthcare. A survey conducted by NextGen Healthcare in 2021 revealed that 83% of ambulatory healthcare providers believe that patient engagement solutions are essential for achieving both financial success and improved patient outcomes, with the COVID-19 pandemic further accelerating market growth.

Gather more insights about the market drivers, restrains and growth of the Global Patient Engagement Solutions Market

Segmentation Analysis:

Delivery Type Insights

In 2023, the web and cloud-based segment dominated the market, holding a substantial 78.0% revenue share, and is projected to experience the fastest growth throughout the forecast period. The increasing adoption of these solutions is attributed to their ability to provide remote access to real-time data tracking, integrated features, easy accessibility, low handling costs, and straightforward data backup. Consequently, companies are increasingly investing in web and cloud-based patient engagement solutions. For instance, Microsoft introduced Microsoft Cloud for Healthcare in May 2020, aiming to enhance patient engagement and facilitate collaboration among healthcare teams through telehealth and data analytics capabilities.

On-premise services also play a crucial role, offering secure patient data management and ease of access, driven by the desire for comprehensive information access within healthcare facilities.

Component Insights

The software and hardware segment accounted for the largest revenue share of 62.7% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. These components form the core offerings of patient engagement solutions, providing intuitive user interfaces and continuous product upgrades that simplify installation, usage, and record retrieval. An example is FollowMyHealth from Allscripts, a widely used mobile-first, customizable patient engagement solution that enhances care quality and patient satisfaction.

The services segment is essential for the effective operation of patient engagement solutions, aiding in their optimization based on customer needs and maximizing health outcomes. This segment encompasses consulting, implementation, training, support and maintenance, as well as services related to interoperability and access to EHR data.

Functionality Insights

In 2023, the communication segment held the largest revenue share at 35.0%, forming the foundational offering of any patient engagement solution. This dominance is driven by the growing demand for telehealth, mHealth, and various virtual communication channels, including audio, video, and text. The pandemic accelerated the adoption of these virtual communication solutions, extending their applications to remote patient monitoring and mental health services.

The health tracking and insights segment is projected to grow at the fastest rate of 19.1% over the forecast period, fueled by the increasing integration of data analytics, artificial intelligence (AI), and machine learning to provide actionable insights for patients and their healthcare providers. For instance, Nuance Communications, Inc. introduced Nuance Mix, a conversational AI platform utilizing deep learning-based speech and natural language understanding technologies. In September 2021, Leidos partnered with Nuance to incorporate this platform and its omnichannel development tools into custom patient engagement solutions.

End-use Insights

The providers segment captured the largest revenue share, exceeding 47.0% in 2023. Providers, who cater to the highest volume of patients and serve as the primary point of contact for health consultations, are the leading adopters of patient engagement solutions. For example, in December 2021, Northwell Health in the U.S. implemented a patient engagement platform by Playback Health at select clinical sites, promoting mobility and secure sharing of point-of-care medical data.

Conversely, the payers segment is expected to grow at the fastest rate of 18.0% during the forecast period. The expansion of this segment is attributed to the increasing adoption of patient and customer engagement solutions that enable broad coverage and support value-based care delivery. Payers are focusing on managing patient care and ensuring connectivity at every stage of the treatment process.

Therapeutic Area Insights

Chronic disease management dominated the market in 2023, holding a revenue share of over 44.7%. The growing geriatric population in key markets, along with the rising prevalence of chronic diseases and accelerated adoption of digital technologies driven by the COVID-19 pandemic, have significantly contributed to the segment’s large share. Patient engagement solutions facilitate chronic disease management by enabling prevention and detection of conditions and supporting both provider-led and self-management strategies.

The health and wellness segment is projected to experience the fastest growth rate of 18.0% over the forecast period, driven by initiatives from leading companies, an expansion of product offerings covering mental health, weight management, and pregnancy, as well as increased research activities. For instance, in June 2023, Cardinal Health finalized an agreement to transfer its Outcomes business to Transaction Data Systems, enhancing patient engagement and clinical pharmacy solutions, thereby strengthening connections between payers and pharmaceutical companies within its extensive pharmacy network.

Application Insights

Outpatient health management accounted for over 39.0% of the market share in 2023, highlighting its dominance. The segment encompassing research and development (R&D) and preventive care is expected to grow at the fastest rate of 18.0% throughout the forecast period. Patients with chronic conditions require continuous monitoring and updates regarding their health management. The rise of healthcare consumerism has also led patients to become more engaged in care planning, tracking, and optimization.

Patient engagement solutions enable remote connections between patients and their healthcare providers, facilitating the efficient exchange of information, patient feedback, and other health-related data. For example, in November 2019, the CDC funded 13 state-level arthritis management and prevention programs to enhance the quality of life and monitoring for rural arthritis patients. Additionally, the adoption of patient engagement solutions for R&D purposes by medical device manufacturers, pharmaceutical companies, and other life sciences entities is expected to grow significantly due to increasing product availability and demand.

Order a free sample PDF of the Patient Engagement Solutions Market Intelligence Study, published by Grand View Research.

Embolic Protection Devices Market Report: Regulatory Changes Impacting Industry Growth

The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Access the Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 – 2030

Embolic Protection Devices Market Report Highlights

Distal filter devices segment emerged as the largest segment owing to high demand for these devices

Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders

North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period

Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region

The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Key Embolic Protection Devices Company Insights

Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry.

Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.

Order your free sample copy of “Embolic Protection Devices Market Report 2024 – 2030, published by Grand View Research

Key Embolic Protection Devices Companies:

The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.

Boston Scientific Corporation
Edwards Lifesciences Corporation.
Abbott.
Medtronic
Cardinal Health.
Innovative Cardiovascular Solutions, LLC
Transverse Medical, Inc.
W. L. Gore & Associates, Inc.

Recent Developments

In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR).

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Enterprise Content Management Market Challenges: Navigating Compliance and Security Risks

The global enterprise content management market size is expected to reach USD 102.01 billion by 2030, according to a study conducted by Grand View Research, Inc., registering a CAGR of 15.1% from 2024 to 2030. Soaring need for securing confidential data is triggering the adoption of enterprise content management (ECM) software. Components of the software include solutions and services such as document management, web content management, records management, document collaboration, and digital rights management. These solutions enable enterprises to reduce their data storage costs and enhance productivity by allowing them to collaborate with employees.

In North America, availability of advanced IT infrastructure and presence of prominent IT giants such as IBM and Microsoft Corporation is poised to drive the adoption of enterprise content management software. Latin American and MEA are projected to witness considerable growth over the coming years owing to growing preference of enterprises for cloud and rising need for IT services by the government sector.

However, vendor dependence and high cost of maintenance are likely to hamper the growth of the market. To overcome this, ECM providers may offer flexibility to enterprises and low-cost maintenance services for gaining credence among organizations.

Access the Enterprise Content Management Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment (Cloud And On-Premise), By Enterprise Size, By Application, By Region, And Segment Forecasts, 2024 – 2030

Enterprise Content Management Market Report Highlights

The services segment is expected to post the highest CAGR of over 17.0% during the forecast period due to growing emphasis on periodic maintenance and employee training to enhance operational efficiencies

Cloud-based ECM provides benefits such as high service level, which will drive the growth of the segment over the forecast period. The segment is anticipated to command more than 55.6% % of the overall market revenue by 2030.

The North America enterprise content management market accounted for the largest market revenue share of 41.1% in 2023

Key Enterprise Content Management Company Insights

Some of the key companies in the enterprise content management market include Microsoft Corporation, IBM Corporation, OpenText Corporation, Hyland Software, Inc., Alfresco Software, Inc., and M-Files Corporation. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

Microsoft Corporation provides a comprehensive suite of ECM solutions catering to modern businesses’ diverse needs. From document management to collaboration tools to data protection, Microsoft’s offerings empower organizations to manage their digital content while ensuring security and compliance efficiently.

IBM Corporation provides a full range of Enterprise Content Management (ECM) solutions through IBM FileNet. FileNet offers a centralized place to securely store and organize all your business data, such as documents, emails, images, and more.

Order your free sample copy of “Enterprise Content Management Market Report 2024 – 2030, published by Grand View Research

Key Enterprise Content Management Companies:

The following are the leading companies in the enterprise content management market. These companies collectively hold the largest market share and dictate industry trends.

Microsoft Corporation
IBM Corporation
OpenText Corporation
Hyland Software, Inc.
Alfresco Software, Inc.
M-Files Corporation
Oracle Corporation
Box, Inc.
Laserfiche
DocuWare Corporation

Recent Developments

In January 2024, Microsoft announced the expansion of its Copilot feature, aiming to bring its full power to more people and businesses. This move signifies Microsoft’s commitment to enhancing productivity and collaboration through innovative AI technologies.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Therapeutic Drug Monitoring Market Challenges: Overcoming Data Management Issues

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Access the Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 – 2030

Therapeutic Drug Monitoring Market Report Highlights

The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.

The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.

The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.

The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Key Therapeutic Drug Monitoring Company Insights

Some of the key companies in the therapeutic drug monitoring market are Abbott, ALPCO, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Chromsystems Instruments & Chemicals GmbH, F.Hoffmann-La Roche Ltd., Randox laboratories Ltd, Siemens Healthineers AG., and biomérieux, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.

Abbott, known for its diagnostic technologies, offers a range of products and solutions tailored to monitor drug levels in patients effectively. These include assays and instruments that aid healthcare providers in optimizing medication dosages, ensuring efficacy, and enhancing patient safety across various therapeutic areas.

ALPCO (American Laboratory Products Company) is a player in the therapeutic drug monitoring market, specializing in providing high-quality assays and immunoassay kits. These products are designed to accurately measure drug levels in patient samples, supporting healthcare providers in optimizing therapeutic outcomes and patient management.

Order your free sample copy of “Therapeutic Drug Monitoring Market Report 2024 – 2030, published by Grand View Research

Key Therapeutic Drug Monitoring Companies:

The following are the leading companies in the therapeutic drug monitoring market. These companies collectively hold the largest market share and dictate industry trends.

Abbott
ALPCO
Beckman Coulter, Inc
Bio-Rad Laboratories, Inc
Thermo Fisher Scientific Inc.
Chromsystems Instruments & Chemicals GmbH
F.Hoffmann-La Roche Ltd.
Randox laboratories Ltd
Siemens Healthineers AG.
biomérieux, Inc.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Soup Market Challenges: Addressing Supply Chain Issues and Quality Concerns

The global soup market size is expected to reach USD 26.21 billion by 2030, registering a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing demand for processed, ready to eat, and packed food and increasing women workforce are expected to increase the market demand in the upcoming years. In addition, increase in disposable income and changing consumer lifestyle in emerging economies including China and India are anticipated to increase the demand for soups.

Consumption of canned and dried soup products is increasing in North America and Europe, on account of continuous product innovation as per customer behavior and preferences. In addition, growing economic independence among women is increasing the consumption of packed and processed food products in the developed countries.

Access the Soup Market Size, Share & Trends Analysis Report By Product (Canned, Dried, UTH), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Online), By Region And Segment Forecasts, 2024 – 2030

Soup being a healthy source of vitamins, minerals, nutrition, and protein serves as a prominent replacement for home cooked food. Therefore, this evolution in the working population is anticipated to significantly influence the demand for soup in future. Demand for soups in restaurants, food outlets, and food joints is expected to acquire a small market share due to growing consumer preference for ready to eat products and rising inclination towards healthy food habits.

Continuous use of cornstarch and salt in canned and dried soup products is expected to act as a restraining factor in the global market. High consumption of corn starch can lead to several health issues like increased level of blood sugar and blood pressure. However, continuous product development by companies such as Campbell Soup Company, which provides new flavors like roasted red pepper and tomato, butternut squash and sweet potato, and harvest carrot and ginger, is expected to influence the buying behavior of the younger population across the globe. The market leaders are focusing on developing new flavors and products in order to make their style statement in the market.

Soup Market Report Highlights

By product, The UHT (ultra-high temperature) segment is expected to register the fastest CAGR during the forecast period. The growth of UHT soups is driven by long-shelf-life ingredients that don’t require refrigeration, making them ideal for busy lifestyles and reducing meal waste.

The dried segment accounted for the largest market revenue share of 59.5% in 2023. The Growing demand for convenient and prepared-to-eat food alternatives, specifically in busy city populations, offers a significant opportunity for producers to innovate and expand their product services.

The supermarkets/hypermarkets segment dominated the market in 2023. Supermarkets/hypermarkets offer various soup varieties from different brands and nutritional needs, providing consumers with vast choices and convenient shopping in the same place.

The Europe region dominated the market with a revenue share of 38.9% in 2023. The climate in Europe also plays a role in the growth of the soup market.

Order your free sample copy of “Soup Market Report 2024 – 2030, published by Grand View Research

Key Soup Company Insights

The Soup Market is witnessing substantial growth in the coming years, driven by way of numerous key techniques and factors. Market players are increasingly focusing on product innovation and development to fulfill evolving customer needs and options.

The Campbell Soup Company offers a variety of products, including canned soups, stocks, broths, and sauces. Its product lineup also features snacks such as Goldfish crackers and Milano cookies, beverages such as V8 juices, and pasta sauces under the Prego brand.

Nestle is food & beverage company which operates in various segments including baby food, bottled water coffee, dairy products, and others. The brand also includes Nescafe, KitKat, and Purina. Nestle emphasizes nutrition, health, and wellness in its product offerings.

Key Soup Companies:

The following are the leading companies in the soup market. These companies collectively hold the largest market share and dictate industry trends.

Associated British Foods plc
Baxters Food Group Limited
Campbell Soup Company
Conagra Brands, Inc.
General Mills, Inc.
Hindustan Unilever Limited
Nestlé S.A
Ottogi Co., Ltd
Premier Foods Group Limited
The Kraft Heinz Company

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Sheet Molding and Bulk Molding Compound Market: Addressing Challenges in Supply Chain Management

The global sheet molding and bulk compound market size is expected to reach USD 5.90 billion by 2030, registering a CAGR of 6.39% from 2024 to 2030, according to a new report by Grand View Research, Inc.
Sheet molding compound (SMC) is widely used in transportation applications because of its excellent mechanics and lightweight nature. They have electrical insulation and are resistant to fire, corrosion, and stains. Traditional materials such as steel, iron, and aluminum are being supplanted by SMC and BMC due to their distinct perceived benefits. Automobile makers are probably going to rely less on steel and more on sheet molding compound (SMC) as the market for lightweight materials and solid compounds grows.

The report “Sheet Molding And Bulk Molding Compound Market Size, Share & Trends Analysis Report By Resin Type (Epoxy, Polyester), By Fiber Type (Glass Fiber, Carbon Fiber), By Application, By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

In addition to the intrinsic limits of metals and their rising costs, a number of firms are substituting metal for thermoset composites in high-performance applications. This is helping to drive the expansion of the sheet molding compound (SMC) market. Many firms now favor lightweight materials because of the direct correlation between fuel usage and the weight of the materials used in manufacturing.
The market offers a lot of room for expansion and innovation, especially in the area of environmentally friendly and sustainable composites development. Global attention to sustainability and minimizing environmental effect has led to an increase in demand for recyclable or renewable materials. Producers are allocating resources to R&D in order to develop recyclable composites and bio-based resins that preserve the performance attributes of conventional SMC and BMC. Moreover, the growing utilization of these materials in developing sectors including infrastructure construction and renewable energy presents fresh opportunities for market participants to flourish.

Sheet Molding And Bulk Molding Compound Market Report Highlights:
Based on fiber type, glass fiber held the market with the largest revenue share of 63.07% in 2023. Glass fiber is the most commonly used reinforcement material in SMC and BMC due to its excellent mechanical properties, cost-effectiveness, and versatility
Based on application, automotive & transportation held the market with the largest revenue share of 31.23% in 2023. The automotive & transportation sector is a major driver of market growth, as SMC and BMC materials are increasingly used for manufacturing lightweight and high-strength components, such as body panels, bumpers, and structural parts
North America holds a substantial share of the market, driven by robust demand from the automotive and aerospace industries. The U.S., in particular, is a major contributor, with its strong manufacturing base and technological innovation
Order your free sample copy of “Sheet Molding And Bulk Molding Compound Market Report 2024 – 2030, published by Grand View Research

Sheet Molding And Bulk Molding Compound Market Segmentation
Grand View Research has segmented the global sheet molding and bulk molding compound market based on resin type, fiber type, application, and region:
Sheet Molding And Bulk Molding Compound Resin Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Epoxy
Polyester
Sheet Molding And Bulk Molding Compound Fiber Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Glass Fiber
Carbon Fiber
Sheet Molding And Bulk Molding Compound Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Automotive & Transportation
Aerospace
Electrical & Electronics
Building & Construction
Domestic Appliances
Others
Sheet Molding And Bulk Molding Compound Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
South Korea
Central & South America
Brazil
Argentina
MEA
South Africa
Saudi Arabia

List of Key Players in the Sheet Molding And Bulk Molding Compound Market
IDI Composites International
National Composites
MENZOLIT
Polynt (Polynt-Reichhold)
Continental Structural Plastics Inc. (TEIJIN)
ZOLTEK (Toray Group)
Mitsui Chemicals
TORAY INTERNATIONAL
Core Molding Technologies
Devi Polymers Private Limited
Zhejiang Yueqing SMC & BMC Manufacture Factory
Huayuan Advanced Materials Co., Ltd.
Resonac Holdings Corporation

About Grand View Research:
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Hydrogel-based Drug Delivery System Market Key Insights: Navigating Emerging Trends

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Access the Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 – 2030

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023

The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology

The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength

Based on delivery route, the ocular segment accounted for the largest revenue share in 2023

The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out

North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems

In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Order your free sample copy of “Hydrogel-based Drug Delivery System Market Report 2024 – 2030, published by Grand View Research

Key Hydrogel-based Drug Based Delivery System Company Insights

Some key companies in the market include GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch + Lomb; Medtronic; and Ocular Therapeutix, Inc. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other emerging and prominent industry participants.

Ocular Therapeutix, Inc., is a biopharmaceutical company that specializes in creating, advancing, and marketing new treatments for eye disorders. It employs its own bioresorbable hydrogel-based formulation technology, ELUTYX. The company has manufacturing facilities in Massachusetts.

Blairex Laboratories, Inc., a global pharmaceutical company, delivers products related to the consumer and pharmaceutical industry. Some of the company’s major offerings are sterile saline solutions and contact lens care.

Key Hydrogel-based Drug Delivery System Companies:

The following are the leading companies in the hydrogel-based drug delivery system market. These companies collectively hold the largest market share and dictate industry trends.

GALDERMA
Blairex Laboratories, Inc
Johnson & Johnson
Bausch + Lomb.
Medtronic
Ocular Therapeutix, Inc.
Ferring B.V.
Endo, Inc.
Tolmar Inc

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Military Wearable Medical Devices Market Key Insights: Navigating Emerging Trends

The global military wearable medical devices market size is expected to reach USD 38.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 26.3% from 2024 to 2030. The growth of the market is attributed to the improvement in the overall performance of military soldiers with the help of innovative technology and the rising demand for lightweight military devices.

The Covid-19 pandemic has transformed the market for military wearable medical devices because wearable technologies could monitor, detect, and prevent the spread of the virus. The Covid-19 virus has indirectly increased the demand for wearable medical devices. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth and it is difficult to identify the virus during the initial days of contract. Hence, with the innovative technology, the individual can regularly check and monitor their body temperature, oxygen level, heart rate, and body performance so that if they found any negative result, then they can immediately take precautions and treatment.

Access the Military Wearable Medical Devices Market Size, Share & Trends Analysis Report By Application (Heart, Performance Monitor), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 – 2030

As soldiers have to train and work in a rough and harsh environment, the wearable device they are carrying must be lightweight and must provide full information of the soldier’s health and performance. Many market players are developing and introducing such wearable devices, which can bear the toughest environment of the battlefield. With the help of the device, armed forces can track and monitor the sleep of every individual, circadian stability, and all physical activity so that they can make necessary changes for better results as per the data.

As per the soldier modernization program, the military has decided to opt for lightweight wearable devices as soldiers already have to carry heavy stuff with them and such devices can increase the speed of the movement. The devices should be easy to carry and made of the toughest material to adapt to the environment. These devices should result in the betterment of the overall performance of the individuals.

Military Wearable Medical Devices Market Highlights

By application, the heart monitor segment held the largest revenue share in 2023 as the system directly detects any uncertain change in the health of an individual, and the patient can be treated as early as possible

North America led the market in 2023 and is expected to maintain its lead over the forecast period owing to technological advancements and increasing R&D investment in military devices

Asia Pacific is expected to witness the fastest growth over the forecast period due to the rising cardiovascular events in the region and rising healthcare spending

The industry is highly competitive with players who are developing advanced medical devices for the soldiers that can be used in war zones or in extreme environments

Order your free sample copy of “Military Wearable Medical Devices Market Report 2024 – 2030, published by Grand View Research

Key Military Wearable Medical Devices Company Insights

Some key companies in the market include Samsung, Bittium, Garmin, Apple Inc., Fitbit, and GOQii. Companies are focusing on longer battery life, connectivity, and accurate readings in the devices.

Garmin has been deploying products in segments such as automotive, marine, aviation, sports & outdoor with a focus on rugged use and long battery life providing a wide range of services through their devices such asMulti-GNSS Support, ABC sensors, trackback routing, geocaching, point-to-point navigation, compass, GPS compass.

Apple Inc. monitors heart rates, fall detection, blood oxygen level, and AFib history with the help of an electrical heart sensor in their product.

Key Military Wearable Medical Devices Companies:

The following are the leading companies in the military wearable medical devices market. These companies collectively hold the largest market share and dictate industry trends.

Bittium
Polar Electro
Oura
Garmin
NeuroMetrix
GOQii
Apple Inc.
Samsung
Fitbit
Zephyr Technology Corporation
Camntec

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Metaverse in Education Market Challenges: Overcoming Barriers to Adoption

The global metaverse in education market size is expected to reach USD 41.62 billion by 2030 and is anticipated to grow at a CAGR of 38.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market drivers include the growing popularity of experiential learning, the easy availability and adoption of Internet services, and the rising demand for interactive learning. The metaverse serves as a medium for various customers such as students to engage in engaging virtual presentations and real time learning experiences, to make them explore historical events, and to conduct scientific experiments in realistic environments. Moreover, these platforms can create virtual space, serving opportunities to connect with people located anywhere in the world and enhance their interactions, and problem-solving abilities among children. This further leads to a collaborative learning environment and can be especially beneficial for geographically dispersed students.

Educational organizations are facing several problems in the act of providing superior educational settings and tech-driven education to students. Metaverse provides real time based technology to experience excellent learning experiences with the help of virtual presentations, thereby raising interactions among students and offering knowledge most interestingly. Various institutions are investing heavily in incorporating metaverse into their in-person and online courses to reduce cognitive burden.

The report “Metaverse in Education Market Size, Share & Trends Analysis Report By Component, By Application (Skill Development, Educational Apps), By End Use (Academic, Corporate), By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

Metaverse in Education Market Report Highlights:

The hardware segment led the market and accounted for over 47.0% share of the global revenue in 2023. Hardware manufacturers are constantly innovating to create VR headsets, AR glasses, and other devices that offer a more immersive and user-friendly experience
Based on application, the educational apps segment is predicted to grow at a significant CAGr from 2024 to 2030. The easy accessibility of educational apps on devices such as tablets or smartphones makes them a more affordable entry point for schools and individual learners thereby increasing their demand
Based on end use, the academic segment accounted for the largest revenue share in 2023 owing to the more engaging and interactive learning environment offered by the metaverse, motivates students to participate actively
North America dominated with a revenue share of over 35.0% in 2023. North America has a well-established EdTech industry with a history of innovation and investment in new learning technologies.

Order your free sample copy of “Metaverse In Education Market Report 2024 – 2030, published by Grand View Research

Metaverse in Education Market Segmentation:

Grand View Research has segmented the global metaverse in education market based on the component, application, end use, and region:

Metaverse in Education Component Outlook (Revenue, USD Billion, 2017-2030)
Hardware
- AR Devices
- VR Devices
- MR Devices
- Interactive Displays and Projectors
Software
- Extended Reality Software
- Gaming Engines
- Metaverse Platforms
- 3D Mapping, Modelling, and Reconstruction
Professional Services
- Application Development and System Integration
- Strategy & Business Consulting
Metaverse in Education Application Outlook (Revenue, USD Billion, 2017-2030)
Learning
Skill Development
Educational Apps
Self-Regulation Skills
Cultural Understanding
Others
Metaverse in Education End Use Outlook (Revenue, USD Billion, 2017-2030)
Academic
- K-12
- Higher Education
Corporate
Metaverse in Education Regional Outlook (Revenue, USD Billion, 2017-2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
MEA
UAE
South Africa
KSA

List of Key Players in the Metaverse in Education:

Adobe Inc.
Baidu Inc.
Epic Games
HP Inc.
Lenovo
Meta
Microsoft Corporation
Roblox Corporation
Samsung Electronics
Unity Software Inc.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Polymer Binders Market Research: Analyzing Trends in the Construction Sector

The global polymer binders market size is expected to reach USD 56.68 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to increasing urbanization, the construction and automotive industries, public infrastructure development, and innovation in polymer technology, which are expected to fuel the growth.

The global market is experiencing a trend of using lightweight materials to improve fuel efficiency and reduce emissions in several industries, including automotive and aerospace, which is creating opportunities for polymer binders used in composite materials and lightweight components.

The report “Polymer Binders Market Size, Share & Trends Analysis Report, By Type (Acrylic, Vinyl Acetate, Latex, Polyurethane, Polyester), By Form, By Application, By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

Moreover, introducing advanced manufacturing technologies such as 3D printing and smart manufacturing can drive demand for innovative polymer binders that increase productivity and compatibility with these technologies.

However, polymer binders market restraints can be volatility in raw material prices, such as petroleum-based products and specialty chemicals. Price fluctuations impact production costs and profit margins, making it difficult for companies to maintain stable pricing strategies.

Polymer Binders Market Report Highlights:

· Based on type, vinyl acetate dominated polymer binders market with a share of over 33 % in 2023 due to wide utilization in several construction applications, including coatings, sealants, and adhesive

· Based on form, the powder segment accounted for the largest revenue share of over 58% in 2023. The powder is helpful in dry mix mortars, as it offers improved workability, adhesion, and durability.

· Based on application, paints & coatings dominated the polymer binders market in 2023 with a revenue share of over 37%. The growth is attributed to coating applications, which provide a range of benefits, such as durability, adhesion, and increased resistance to abrasion.

· North America polymer binders market is expected to grow at a significant rate of 7.4% from 2024 to 2030. The market is witnessing demand for high-performance and environmentally friendly binders across several industries including construction.

Order your free sample copy of “Polymer Binders Market Report 2024 – 2030, published by Grand View Research

Polymer Binders Market Segmentation

Grand View Research has segmented the global polymer binders market based on type, form, application, and region:

Polymer Binders Type Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 – 2030)

· Acrylic

· Vinyl Acetate

· Latex

· Polyurethane

· Polyester

· Others

Polymer Binders Form Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 – 2030)

· Powder

· Liquid

· High Solids

Polymer Binders Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 – 2030)

· Paints & Coatings

· Adhesives

· Textiles

· Construction

· Others

Polymer Binders Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 – 2030)

· North America

o U.S.

o Canada

o Mexico

· Europe

o Germany

o UK

o Italy

o Spain

o France

o The Netherlands

o Denmark

· Asia Pacific

o China

o India

o Japan

o South Korea

o Indonesia

· Central & South America

o Brazil

o Argentina

· Middle East & Africa

o UAE

o Saudi Arabia

o South Africa

List of Key Players in the Polymer Binders Market

· BASF SE

· Wacker Chemie AG

· OMNOVA Solutions Inc.

· Celanese Corporation

· Arkema

· Dairen Chemical Corporation

· Toagosei Co. Ltd.

· Guangdong Yinyang Environment-Friendly New Materials Co., Ltd.

· Weifang Tainuo Chemical Co., Ltd.

· Mayfair Biotech Pvt. Ltd.

· VINAVIL S.p.A.

· The Lubrizol Corporation

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com